Page last updated: 2024-11-02

papaverine and Myocardial Infarction

papaverine has been researched along with Myocardial Infarction in 35 studies

Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.

Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).

Research Excerpts

ExcerptRelevanceReference
"In a randomized, double-blind prospective study involving 495 patients, we investigated whether the addition of papaverine, 60 mg, to our existing regimen of cold cardioplegia would reduce myocardial necrosis during elective coronary artery bypass operations."9.06Addition of papaverine to cardioplegia does not reduce myocardial necrosis. ( Cooley, DA; Duncan, JM; Frazier, OH; Keats, AS; Livesay, JJ; Ott, DA; Reul, GJ; Slogoff, S, 1986)
"In order to evaluate coronary flow response to 2 different vasodilators, nicorandil and papaverine, in patients with myocardial infarction, we measured coronary flow reserve using a Doppler guide wire in infarct-related and non infarct-related arteries."7.70[Coronary flow after successful angioplasty in patients with acute myocardial infarction: comparison between coronary flow reserve by nicorandil and papaverine]. ( Gen, H; Himura, Y; Hirozane, T; Iga, K; Inoko, M; Izumi, C; Kitaguchi, S; Kondo, H; Konishi, T; Tamura, T, 2000)
"3 mg Atropinmethylnitrat, without phenobarbital) was given in a dosis of 3 and 6 tablets in patients with acute myocardial infarction."7.65[The effect of nitroglycerin in patients with acute myocardial infarction. IV. Myocardon in patients with and without left ventricular failure (author's transl)]. ( Bussmann, WD; Kaltenbach, M; Löhner, J, 1976)
"In a randomized, double-blind prospective study involving 495 patients, we investigated whether the addition of papaverine, 60 mg, to our existing regimen of cold cardioplegia would reduce myocardial necrosis during elective coronary artery bypass operations."5.06Addition of papaverine to cardioplegia does not reduce myocardial necrosis. ( Cooley, DA; Duncan, JM; Frazier, OH; Keats, AS; Livesay, JJ; Ott, DA; Reul, GJ; Slogoff, S, 1986)
"This study sought to elucidate serial changes in microvascular integrity during papaverine-induced hyperemia in the risk area for myocardial infarction."3.71Optimal time for predicting myocardial viability after successful primary angioplasty in acute myocardial infarction: a study using myocardial contrast echocardiography. ( Fujiwara, H; Hayashi, Y; Imazu, M; Okimoto, T; Otsuka, M; Sakuma, T; Sumii, K, 2001)
"We investigated the usefulness of the intracoronary administration of nicorandil (NIC) compared with that of papaverine (PAP) in the evaluation of coronary flow reserve (CFR) in 17 patients, including 10 patients with old myocardial infarction and 7 patients with angina pectoris."3.70Estimation of coronary flow reserve by intracoronary administration of nicorandil: comparison with intracoronary administration of papaverine. ( Dohi, K; Fujimoto, S; Hashimoto, T; Inoue, F; Kawamoto, A; Uemura, S, 1998)
"In order to evaluate coronary flow response to 2 different vasodilators, nicorandil and papaverine, in patients with myocardial infarction, we measured coronary flow reserve using a Doppler guide wire in infarct-related and non infarct-related arteries."3.70[Coronary flow after successful angioplasty in patients with acute myocardial infarction: comparison between coronary flow reserve by nicorandil and papaverine]. ( Gen, H; Himura, Y; Hirozane, T; Iga, K; Inoko, M; Izumi, C; Kitaguchi, S; Kondo, H; Konishi, T; Tamura, T, 2000)
"The authors realized a retrospective clinical-statistical study about 121 cases of acute myocardial infarction (AMI), treated in the Department of general medicine with a pharmacological association of Lysine acetylsalicylate--Erythrityl tetranitrate--Papaverine hydrochloride, with the purpose of obtaining a vasodilatation on coronary arteries and a platelet antiaggregation, in the light of the new etiopathogenetic views about the prolonged coronary spasm and the platelet aggregation, in some cases of myocardial infarction with or without thrombosis."3.66[Clinical and statistical study of 121 cases of acute myocardial infarct from 1976 to 1981 (month of April). Critical review]. ( Carile, L; Di Falco, C; Laquaglia, GA; Marchionni, F; Martone, P, 1982)
" All compounds were evaluated for their ability to protect against chloroform-induced ventricular fibrillation in mice."3.65Isoquinolines. 5. Synthesis and antiarrhythmic activity of benzylisoquinoline derivatives. ( Neumeyer, JL; Perianayagam, C; Ruchirawat, S, 1977)
"3 mg Atropinmethylnitrat, without phenobarbital) was given in a dosis of 3 and 6 tablets in patients with acute myocardial infarction."3.65[The effect of nitroglycerin in patients with acute myocardial infarction. IV. Myocardon in patients with and without left ventricular failure (author's transl)]. ( Bussmann, WD; Kaltenbach, M; Löhner, J, 1976)
"The restenosis rate after recanalization of chronic totally occluded coronary arteries is high."1.29Restoration of coronary blood flow in severely narrowed and chronically occluded coronary arteries before and after angioplasty: implications regarding restenosis. ( Dubois-Randé, JL; Dupouy, P; Geschwind, HJ; Zelinsky, R, 1994)

Research

Studies (35)

TimeframeStudies, this research(%)All Research%
pre-199025 (71.43)18.7374
1990's7 (20.00)18.2507
2000's2 (5.71)29.6817
2010's1 (2.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Neumeyer, JL1
Perianayagam, C1
Ruchirawat, S1
Sun, Z1
Tong, G1
Kim, TH1
Ma, N1
Niu, G1
Cao, F1
Chen, X1
HARRIS, AS1
ESTANDIA, A1
BISTENI, A1
SMITH, HT1
RIECKER, HH1
STREIT, M1
TAESCHLER, M1
KALLENBERG, L1
KOBAYASHI, T1
TAKEUCHI, M1
FAZEKAS, JF1
ALMAN, RW1
TICKTIN, HE1
EHRMANTRAUT, WR1
SAVARESE, CJ1
LUSTOK, MJ1
Carile, L1
Laquaglia, GA1
Martone, P1
Marchionni, F1
Di Falco, C1
Schlack, W1
Uebing, A1
Schäfer, M1
Bier, F1
Grunert, S1
Ebel, D1
Piper, HM1
Thämer, V1
Suryapranata, H1
Zijlstra, F1
MacLeod, DC1
van den Brand, M1
de Feyter, PJ1
Serruys, PW1
Klauss, V1
Meissner, O1
Metz, J1
Theisen, K1
Mudra, H1
Geschwind, HJ1
Dupouy, P1
Dubois-Randé, JL1
Zelinsky, R1
Ishihara, M1
Sato, H1
Tateishi, H1
Kawagoe, T1
Shimatani, Y1
Kurisu, S1
Sakai, K1
Neumann, FJ1
Blasini, R1
Schmitt, C1
Alt, E1
Dirschinger, J1
Gawaz, M1
Kastrati, A1
Schömig, A1
Inoue, F1
Hashimoto, T1
Fujimoto, S1
Uemura, S1
Kawamoto, A1
Dohi, K1
Izumi, C1
Kondo, H1
Tamura, T1
Inoko, M1
Kitaguchi, S1
Hirozane, T1
Himura, Y1
Iga, K1
Gen, H1
Konishi, T1
Sakuma, T1
Otsuka, M1
Okimoto, T1
Fujiwara, H1
Sumii, K1
Imazu, M1
Hayashi, Y1
Melloni, GF1
Lureti, GF1
Minoja, GM1
Melloni, CF1
Scarlatti, GF1
Facchetti, M1
Fassini, G1
Schroeder, JS1
Kipsidzen, N1
Kikava, GM1
Bussmann, WD1
Löhner, J1
Kaltenbach, M1
Köhler, U1
Cifaldi, S1
Viglietto, A1
Marone, G1
Azzinnari, G1
Colantuoni, A1
Slogoff, S1
Keats, AS1
Cooley, DA1
Reul, GJ1
Frazier, OH1
Ott, DA1
Duncan, JM1
Livesay, JJ1
Severin, SE1
Zoli, I1
Baroncini, S1
Cornia, GL1
Donato, S1
Minore, G1
Pigini, G1
Pretolani, E1
Mikaeloff, P1
Amiel, L1
Delaye, J1
Roques, JC1
Age, C1
Saint-Pierre, A1
Dupont, JC1
Eyraud, J1
Sassard, M1
Levin, AI1
Vaĭnberg, AG1
Votcal, BE1
Lozinskij, LG1
Monroe, RG2
LaFarge, CG2
Gamble, WJ2
Kumar, AE2
Manasek, FJ1
Stark, J1
Sanders, GL1
Phornphutkul, C1
Davis, M1
Huttman, DH1
Amadini, S1
Bagnoli, L1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Value of Abciximab in Patients With AMI Undergoing PCI After High Dose Clopidogrel Pretreatment (BRAVE 3)[NCT00133250]Phase 4800 participants (Actual)Interventional2003-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for papaverine and Myocardial Infarction

ArticleYear
CURRENT THERAPEUTIC CONCEPTS OF CEREBRAL AND MYOCARDIAL VASCULAR DISEASE.
    Angiology, 1964, Volume: 15

    Topics: Acetazolamide; Anticoagulants; Brain Ischemia; Cerebrovascular Disorders; Coronary Disease; Histamin

1964

Trials

6 trials available for papaverine and Myocardial Infarction

ArticleYear
[Contrast echocardiography in the evaluation of myocardial flow reserve].
    Zeitschrift fur Kardiologie, 1993, Volume: 82, Issue:12

    Topics: Adult; Aged; Contrast Media; Coronary Circulation; Coronary Disease; Echocardiography; Female; Hemod

1993
Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction.
    Circulation, 1998, Dec-15, Volume: 98, Issue:24

    Topics: Abciximab; Aged; Antibodies, Monoclonal; Blood Flow Velocity; Coronary Angiography; Female; Heparin;

1998
Newer antiarrhythmic agents for patients with coronary artery disease.
    Angiology, 1978, Volume: 29, Issue:1

    Topics: Acebutolol; Adult; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic;

1978
[On the efficacy of carbocromen in the treatment of myocardial infarction (author's transl)].
    Arzneimittel-Forschung, 1976, Volume: 26, Issue:5

    Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Chromonar; Clinical Trials as To

1976
Addition of papaverine to cardioplegia does not reduce myocardial necrosis.
    The Annals of thoracic surgery, 1986, Volume: 42, Issue:1

    Topics: Clinical Trials as Topic; Constriction; Coronary Artery Bypass; Creatine Kinase; Double-Blind Method

1986
[Carbochromen in therapy of acute and chronic coronary insufficiency].
    Arzneimittel-Forschung, 1970, Volume: 20

    Topics: Acute Disease; Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Chronic Disease;

1970

Other Studies

28 other studies available for papaverine and Myocardial Infarction

ArticleYear
Isoquinolines. 5. Synthesis and antiarrhythmic activity of benzylisoquinoline derivatives.
    Journal of medicinal chemistry, 1977, Volume: 20, Issue:7

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chloroform; Dogs; Female; Isoquinolines; Mice

1977
PEGylated exendin-4, a modified GLP-1 analog exhibits more potent cardioprotection than its unmodified parent molecule on a dose to dose basis in a murine model of myocardial infarction.
    Theranostics, 2015, Volume: 5, Issue:3

    Topics: Aminophylline; Animals; Atropine; Blotting, Western; Cardiovascular Agents; Disease Models, Animal;

2015
Effects of papaverine upon ectopic ventricular tachycardia produced by myocardial infarction.
    Circulation, 1953, Volume: 8, Issue:6

    Topics: Myocardial Infarction; Papaverine; Tachycardia; Tachycardia, Ventricular; Ventricular Premature Comp

1953
Standard management of myocardial infarctions.
    Journal - Michigan State Medical Society, 1955, Volume: 54, Issue:1

    Topics: Anticoagulants; Disease Management; Myocardial Infarction; Papaverine

1955
[Pharmacodynamic studies on experimental cardiac infarcts in rats].
    Acta physiologica et pharmacologica Neerlandica, 1957, Volume: 6

    Topics: Animals; Electrocardiography; Myocardial Infarction; Nitrites; Papaverine; Rats

1957
[On the follow-up treatment of heart infarct with Myocardon].
    Hippokrates, 1963, Mar-31, Volume: 34

    Topics: Aminophylline; Atropine; Drug Combinations; Follow-Up Studies; Humans; Myocardial Infarction; Nitrog

1963
[REHABILITATION IN HEART DISEASE].
    [Chiryo] [Therapy], 1963, Volume: 45

    Topics: Acenocoumarol; Dipyridamole; Electrocardiography; Geriatrics; Heart Defects, Congenital; Heart Disea

1963
Papaverine suppositories in myocardial infarction.
    Wisconsin medical journal, 1952, Volume: 51, Issue:3

    Topics: Cardiovascular Diseases; Coronary Disease; Humans; Myocardial Infarction; Papaverine; Suppositories

1952
[Clinical and statistical study of 121 cases of acute myocardial infarct from 1976 to 1981 (month of April). Critical review].
    Minerva medica, 1982, Apr-02, Volume: 73, Issue:14

    Topics: Adult; Aged; Aspirin; Coronary Vessels; Erythrityl Tetranitrate; Female; Heart Failure; Humans; Lysi

1982
Intracoronary SIN-1C during reperfusion reduces infarct size in dog.
    Journal of cardiovascular pharmacology, 1995, Volume: 25, Issue:3

    Topics: Acetonitriles; Animals; Coronary Circulation; Dogs; Electrocardiography; Female; Infusions, Intraven

1995
Predictive value of reactive hyperemic response on reperfusion on recovery of regional myocardial function after coronary angioplasty in acute myocardial infarction.
    Circulation, 1994, Volume: 89, Issue:3

    Topics: Angiography, Digital Subtraction; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Cir

1994
Restoration of coronary blood flow in severely narrowed and chronically occluded coronary arteries before and after angioplasty: implications regarding restenosis.
    American heart journal, 1994, Volume: 127, Issue:2

    Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Blood Flow Velocity; Blood Pressure; Cardiac Output; Ch

1994
Attenuation of the no-reflow phenomenon after coronary angioplasty for acute myocardial infarction with intracoronary papaverine.
    American heart journal, 1996, Volume: 132, Issue:5

    Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Circulation; Female; Hea

1996
Estimation of coronary flow reserve by intracoronary administration of nicorandil: comparison with intracoronary administration of papaverine.
    Heart and vessels, 1998, Volume: 13, Issue:5

    Topics: Angina Pectoris; Coronary Angiography; Coronary Circulation; Coronary Vessels; Electrocardiography;

1998
[Coronary flow after successful angioplasty in patients with acute myocardial infarction: comparison between coronary flow reserve by nicorandil and papaverine].
    Journal of cardiology, 2000, Volume: 35, Issue:3

    Topics: Angioplasty, Balloon, Coronary; Coronary Circulation; Female; Humans; Male; Middle Aged; Myocardial

2000
Optimal time for predicting myocardial viability after successful primary angioplasty in acute myocardial infarction: a study using myocardial contrast echocardiography.
    The American journal of cardiology, 2001, Mar-15, Volume: 87, Issue:6

    Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Circulation; Echoc

2001
[Comparative statistical study of the treatment of myocardial infarct with anticoagulants and anti-aggregants].
    Bollettino della Societa italiana di cardiologia, 1977, Volume: 22, Issue:7

    Topics: Aged; Anticoagulants; Dicumarol; Dipyridamole; Drug Evaluation; Female; Heparin; Humans; Male; Middl

1977
[The effect of nitroglycerin in patients with acute myocardial infarction. IV. Myocardon in patients with and without left ventricular failure (author's transl)].
    Medizinische Klinik, 1976, Mar-05, Volume: 71, Issue:10

    Topics: Acute Disease; Adult; Aged; Atropine; Blood Pressure; Cardiac Output; Drug Combinations; Female; Hea

1976
[Prevention of myocardial infarct by general practitioner].
    Zeitschrift fur Allgemeinmedizin, 1975, Oct-10, Volume: 51, Issue:28

    Topics: Cardiac Glycosides; Family Practice; Humans; Iontophoresis; Magnesium; Myocardial Infarction; Papave

1975
[Hyperbaric oxygen and coronary dilator agents in experimental necrosis of the myocardium in rats].
    Bollettino della Societa italiana di biologia sperimentale, 1975, Apr-15, Volume: 51, Issue:7

    Topics: Animals; Dipyridamole; Hyperbaric Oxygenation; Myocardial Infarction; Necrosis; Papaverine; Rats; Va

1975
[Basic directions in the study of the biochemistry of the myocardium].
    Kardiologiia, 1967, Volume: 7, Issue:11

    Topics: Adaptation, Physiological; Animals; Camphor; Cardiac Glycosides; Cardiomegaly; Cardiovascular Diseas

1967
[Therapeutic possibilities in coronary disease].
    Minerva medica, 1973, Nov-24, Volume: 64, Issue:84

    Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Arteriosclerosis; Cardiomegaly; Coronary Disease

1973
[Venous aortocoronary bypass. Hemodynamic and morphological study].
    La Nouvelle presse medicale, 1974, Jan-12, Volume: 3, Issue:2

    Topics: Angina Pectoris; Blood Pressure Determination; Catheterization; Coronary Artery Bypass; Extracorpore

1974
[Action of nitroglycerin and intravenous injections of papaverine on the contractile function of the heart in patients with coronary circulatory disorders].
    Kardiologiia, 1969, Volume: 9, Issue:1

    Topics: Adult; Aged; Coronary Disease; Female; Heart; Humans; Hypertension; Injections, Intravenous; Male; M

1969
Left ventricular performance and coronary flow after coronary embolization with plastic microspheres.
    The Journal of clinical investigation, 1971, Volume: 50, Issue:8

    Topics: Animals; Atropine; Blood Pressure; Cardiac Output; Coronary Circulation; Disease Models, Animal; Dog

1971
The Anrep effect reconsidered.
    The Journal of clinical investigation, 1972, Volume: 51, Issue:10

    Topics: Adenosine Triphosphate; Aminophylline; Animals; Blood Flow Velocity; Blood Pressure; Catheterization

1972
[Aspirin in the treatment of myocardial infarct].
    Giornale di clinica medica, 1971, Volume: 52, Issue:10

    Topics: Aspirin; Bicarbonates; Blood Coagulation; Blood Sedimentation; Gastrointestinal Diseases; Hematuria;

1971
[Clinical studies with a new anticoronaritis preparation].
    Minerva cardioangiologica, 1969, Volume: 17, Issue:8

    Topics: Arteriosclerosis; Arteritis; Coronary Disease; Electrocardiography; Humans; Myocardial Infarction; P

1969